Skip to main content
倍益康 logo

倍益康 — Investor Relations & Filings

Ticker · 920199 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2024-04-18 Notice of Dividend Amou…
Country CN China
Listing Beijing Stock Exchange 920199

About 倍益康

https://www.qlbeoka.com/

Beiyikang focuses on the research, development, and manufacturing of rehabilitation and physical therapy equipment. The company integrates professional medical technology with consumer-oriented health solutions. Its product lineup features percussive massage devices, oxygen concentrators, blood pressure monitors, and specialized physical therapy instruments for pain relief and muscle recovery. By utilizing advanced manufacturing processes and technological innovation, Beiyikang delivers products for sports recovery, clinical rehabilitation, and personal health management. The company prioritizes the incorporation of smart technology into its hardware to improve therapeutic outcomes and user experience across its range of recovery and wellness devices.

Recent filings

Filing Released Lang Actions
2023年年度权益分派预案公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the company's 2023 annual profit distribution plan (dividend distribution plan). It includes specifics about the dividend amount, conditions, company bylaws related to profit distribution, and the approval process involving the board and shareholders. It is not the full annual report or financial statements but a formal announcement of the dividend amount and related policies. The document is about the dividend distribution plan and its approval process, which fits the category of Notice of Dividend Amount (DIV). The document length is 4041 characters, which is consistent with a detailed dividend announcement rather than a full annual report or other financial report. Therefore, the correct classification is DIV with high confidence.
2024-04-18 Chinese
2023年度独立董事述职报告（易阳）
Board/Management Information Classification · 95% confidence The document is titled as the "2023年度独立董事述职报告（易阳）" which translates to "2023 Annual Independent Director's Work Report (Yi Yang)". It details the independent director's attendance at board and shareholder meetings, opinions on various company matters, communication with internal audit and accounting firms, and efforts to protect investor rights. The content is a detailed report on the independent director's activities and responsibilities during the year 2023. It is not an announcement of a report publication, nor is it a certification or a brief summary. It is a management-related report focusing on board/management information, specifically the independent director's duties and opinions. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is 3715 characters, which is relatively short but contains substantive content about management activities rather than just an announcement or certification.
2024-04-18 Chinese
东莞证券股份有限公司关于四川千里倍益康医疗科技股份有限公司2023年募集资金存放和使用情况的专项核查报告
Audit Report / Information Classification · 95% confidence The document is titled as a "专项核查报告" (special inspection report) regarding the 2023 annual fundraising funds deposit and usage situation of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It is issued by Dongguan Securities as the sponsor and continuous supervision institution. The document contains detailed information about the amount of funds raised, their deposit, usage, management, and compliance with relevant regulations. It also includes an auditor's verification opinion from an accounting firm. The document is a standalone audit-type report focusing on the verification of fundraising funds usage and compliance, not a full annual report or interim financial report. It is not an announcement or a brief summary but a detailed special inspection report. Therefore, it fits the category of Audit Report / Information (AR). The document length (7265 characters) supports it being a full report rather than a brief announcement or certification only. FY 2023
2024-04-18 Chinese
第三届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 16th meeting of the 3rd Board of Directors of Sichuan Qianli Beiyikang Medical Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various reports such as the 2023 Annual Report, Audit Report, Independent Directors' Reports, and others. The document primarily focuses on board meeting decisions and approvals rather than the full text of any report. It also mentions which reports have been or will be disclosed on the exchange platform. This type of document is a Board/Management Information announcement, as it details board meeting resolutions and management reports approval, not the reports themselves or their publication announcements. The document length (7217 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive board meeting resolution announcement.
2024-04-18 Chinese
审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a report from the Audit Committee regarding the supervision of the accounting firm (auditor) for the fiscal year 2023. It discusses the auditor's qualifications, independence, audit procedures, and the committee's evaluation of the auditor's performance. It does not contain the full audit report or financial statements but rather a supervisory report on the auditor's role and conduct. This matches the definition of an Audit Report / Information filing, which includes standalone audit reports and information about audit processes and oversight, excluding full annual reports. The document length is short (1409 characters), but it is a substantive report, not merely an announcement or certification. Therefore, the correct classification is AR (Audit Report / Information). FY 2023
2024-04-18 Chinese
董事会关于独立董事独立性自查情况专项报告
Governance Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence of the company's independent directors. It references regulatory requirements and rules related to independent directors and confirms their independence status. The content is focused on governance and compliance with independence criteria rather than financial results or other report types. It is not an announcement of a meeting, voting results, or a financial report. The document fits best under Governance Information (CGR) as it details governance practices related to board independence.
2024-04-18 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.